Advancements in Next-gen Sequencing and Genomic Analysis

Description

NGS Platforms and Genomic Analysis to Ensure Transformational Growth of Precision Medicine

Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrated itself into basic life science research to understand disease biology for drug development and diagnostics.

Developments in NGS chemistries such as single-molecule real-time sequencing, sequencing by synthesis, nanopore sequencing, ion and semiconductor technology, in addition to miniaturization of sequencing instrumentation and automation of NGS, boost the adoption of NGS across biological labs. Whole genome sequencing, targeted sequencing, whole exome sequencing, whole transcriptome sequencing, and single-cell RNA sequencing have all found specific applications across omics where they accurately indicate and identify structural variants, SNPs, genetic variations, pathogen detection, patient stratification, drug discovery, and so on.

The NGS market is now witnessing a rise in emerging players that offer improved chemistries and instrumentation to deliver low-cost whole genome sequencing, increasing adoption across geographies and driving precision medicine. Technological advancement of AI-/ML-powered platforms for analyzing sequencing data is helping analyze and interpret large volumes of sequencing data within hours. NGS plays a key role in data-driven clinical medicine and will continue to improve the global healthcare system. The analytics covers developments in NGS and genomic analysis platforms that will make whole genome sequencing more accessible and accelerate early clinical decisions for better health outcomes.

Product Code: DABB

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Advances in Next-Generation Sequencing and Genomic Analysis Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Growth Opportunity Analysis

Scope of Analysis
Growth Drivers
Growth Drivers Analysis
Growth Restraints
Growth Restraints Analysis
Key Findings
Global Trends In Next-gen Sequencing and Genomic Analysis

Technology Innovations and R&D Scenario in Next-generation Sequencing and Genomic Analysis

The Evolution of Sequencing Methods
Key Focus Areas Leading to Improvements in Advanced Sequencing Technologies
The Growing Significance of NGS and its Capabilities
Technology Intervention Improving C
Evolution of NGS from Pyrosequencing to Advanced NGS
NGS Sequencing Chemistries and Their Adoption
Types of NGS Chemistries
Leading Industry Stakeholder Landscape and the NGS Platforms
Ongoing Sequencing Technology Developments of Market Leaders
Strategies that Improve Genomic Outcomes
Emerging Market Players Focus on Automation, AI integration and Improving Sequencing Chemistries
Approaches for Accurate and Fast Nucleic Acid Sequencing Using NGS
Trends in NGS Approaches and Genome Analysis
Advances in Robotics, Liquid handling and Library Preparation Advance NGS Automation Systems
Key Enablers Focusing on Automation for NGS
Role of AI in Driving Genomic Analysis
Key Players Focusing On AI, Bioinformatics Platforms For NGS Analysis
Industry Landscape of NGS Sequencing Providers and Integrated Services

Applications

Growing Adoption of NGS in Various Applications
NGS and Genomic Analysis Improving Mutational Analysis and Biomarker Discovery for Disease Diagnosis
Growing NGS Collaboration and Technology Platforms to Develop Rapid-NGS-based Diagnostic Tests
NGS And Genomic Analysis Improving Predictive Analysis for Precision Medicine
Key Players Focusing on NGS driven Precision Medicine
NGS And Genomic Analysis Improving
Growing NGS - Based Drug Discovery Companies
The Road Ahead for Next-generation Sequencing

R&D Collaborations

A Growing Network Acquisition to Improve NGS Capabilities
Global Public Funding and Consortium Efforts to Encourage Technology Knowledge and Collaboration

Growth Opportunity Universe

Growth Opportunity 1: Affordable Sequencing Services
Growth Opportunity 1: Affordable Sequencing Services
Growth Opportunity 2: Clinical Metagenomics for Low- and Middle-income Countries
Growth Opportunity 3: Platform Security and Regulations
Growth Opportunity 3: Platform Security and Regulations

Appendix

Technology Readiness Levels (TRL): Explanation

Next Steps

Your Next Steps
Why Frost, Why Now?
Legal Disclaimer